Results 161 to 170 of about 5,055,721 (310)
Mendelian randomization in cancer research: opportunities and challenges. [PDF]
Tang M, Chen L.
europepmc +1 more source
Research opportunities in loss of red blood cell mass in space flight [PDF]
Decreases of red blood cell mass and plasma volume have been observed consistently following manned space flights. Losses of red cell mass by United States astronauts have averaged 10 to 15% (range: 2 to 21%).
Fisher, K. D., Talbot, J. M.
core +1 more source
Objective A patient‐centered approach for chronic disease management, including systemic lupus erythematosus (SLE), aligns treatment with patients’ values and preferences, leading to improved outcomes. This paper summarizes how patient experiences, perspectives, and priorities informed the American College of Rheumatology (ACR) 2024 Lupus Nephritis (LN)
Shivani Garg +20 more
wiley +1 more source
Perspective: challenges and research opportunities to enhance African Swine Fever control in the Philippines. [PDF]
Hsu CH +5 more
europepmc +1 more source
Innovation: more than research and development. Growth opportunities on different innovation paths [PDF]
On all levels of economy and society innovations are perceived as key success factor to economic growth and employment. Often it reads as follows: Increased research and development generates technologically innovative products, enabling companies to ...
Kinkel, Steffen +2 more
core
Objective Sjögren's disease is an autoimmune disorder that can impact multiple organ systems, including the peripheral nervous system (PNS). PNS manifestations, which can exist concurrently, include mononeuropathies, polyneuropathies, and autonomic nervous system neuropathies.
Anahita Deboo +88 more
wiley +1 more source
Musculoskeletal research--opportunities for all? [PDF]
Deighton, Chris +2 more
openaire +2 more sources
Objective The goal was to assess the diagnostic performance of three novel autoantibodies (NA) for Sjögren disease (SjD) by comparing NA prevalence in patients with SjD, other autoimmune rheumatic diseases (ARDs), nonspecific chronic sialadenitis (CS), and controls.
Chadwick R. Johr +5 more
wiley +1 more source

